BOOT vs MBLY

BOOT exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The company shows impressive profitability and growth, with 18.7% YoY revenue growth and 44.2% earnings growth, supported by strong margins and solid ROE of 18.74%. However, elevated valuation metrics, insider selling, and weakening near-term earnings momentum contrast with bullish analyst sentiment and strong long-term price performance. The stock trades above the Graham Number of $76.71 and below the growth-based intrinsic value of $195.29, suggesting a fair-to-slightly-rich valuation.

MBLY exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company maintains a pristine balance sheet with negligible debt and high liquidity, this is offset by negative revenue growth (-9.00% YoY) and negative profit margins. The stock is in a clear technical downtrend, having lost over 50% of its value in the last six months. Despite an attractive P/B ratio of 0.51 and bullish analyst targets, the deterministic health markers suggest a high-risk profile until growth stabilizes.